References

  1. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL et al. Nomenclature of systemic vasculitides; Proposal of an international consensus conference. Arthritis Rheum. 1994;37(2):187-92. PubMed | Google Scholar

  2. Evangéline Pillebout. Purpura rhumatoïde de l'adulte. Presse Med. 2008;37: 1773-1778. Google Scholar

  3. Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R et al. EULAR/ PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008, Part II: final classification criteria. Ann Rheum Dis. 2010;69(5):798-806. PubMed | Google Scholar

  4. Rieu P, Noel LH. Henoch-Schönlein nephritis in children and adults; Morpho-logical features and clinicopathological correlations. Ann Med Interne (Paris). 1999;150(2):151-9. PubMed | Google Scholar

  5. Watts RA, Lane S, Scott DG. What is known about the epidemiology of the vasculitides. Best Pract Res Clin Rheumatol. 2005;19(2):191-207. PubMed | Google Scholar

  6. Pillebout E, Verinec J. Purpura rhumatoïde de l'adulte. La Revue de médecine interne. 2014;35(6):372-381. Google Scholar

  7. Couzi L, Cluzeau J, Skopinski S, Constans J, Conri C. Purpura rhumatoïde et cancer de la prostate . Henoch-Schonlein purpura and prostate carcinoma. La revue de médecine interne. 2002;23(8):717-719. PubMed | Google Scholar

  8. Magyarlaki T, Kiss B, Buzogany I, Fazekas A, Sukosd F, Nagy J. Renal cell carcinoma and paraneoplastic IgA nephropathy. Nephron. 1999;82(2):127-30. PubMed | Google Scholar

  9. Adeline Mei-Yen Yong, Shan-Xian Lee, Yong-Kwang Tay. The profile of adult onset Henoch-Sch€onlein purpura in an Asian population. International Journal of Dermatology. 2015;54(11):1236-241. PubMed | Google Scholar

  10. Lasseur C, Rispall P, Combe C, Pellegrinl JL, de Precigout V, Aparicio M et al. Purpura rhumatoïde de l'adulte; a propos de 40 observations. Rev Med int. 1996;738 1-389. Google Scholar

  11. Sallière D, Segond P, Grange MJ, Masiass P. Manifestations digestives sévères du purpura rhumatoïde de l'adulte. Sem Hop Paris. 1982;58:59-72.

  12. See A, Verger MF, Bouvry M. Enteropathie exsudative au cours du purpura rhumatoïde de l'adulte; Mise en évidence par la clearance de l'alpha-antitrypsine. Srfn Hrip Paris. 1986;62:1923-5.

  13. Garcia-Porrua C, Calvino MC, Llorca J, Couselo JM, Gonzalez-Gay MA. Henoch-Schonlein purpura in children and adults: clinical differences in a defined population. Semin Arthritis Rheum. 2002;32(3):149-56. PubMed | Google Scholar

  14. Trapani S, Micheli A, Grisolia F, Resti M, Chiappini E, Falcini F et al. Henoch Schonlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature. Semin Arthritis Rheum. 2005;35(3):143-53. PubMed | Google Scholar

  15. Coppo R, Mazzucco G, Cagnoli L, Lupo A, Schena FP. Long-term prognosis of Henoch-Schönlein nephritis in adults and children. Italian Group of Renal Immunopathology Collaborative Study on Henoch-Schönlein purpura.Nephrol Dial Transplant. 1997;12(11):2277-83. PubMed | Google Scholar

  16. Garcia-Porrua C, Gonzalez-Louzao C, Llorca J, Gonzlez-Gay MA. Predictive fac-tors for renal sequelae in adults with Henoch-Schönlein purpura. J Rheumatol. 2001;28(5):1019-24. PubMed | Google Scholar

  17. Rauta V, Tornroth T, Gronhagen-Riska C. Henoch-Schoenlein nephritis in adults-clinical features and outcomes in Finnish patients. Clin Nephrol. 2002;58(1):1-8. PubMed | Google Scholar

  18. Coppo R, Andrulli S, Amore A, Gianoglio B, Conti G, Peruzzi L et al. Predictors of outcome in Henoch-Schönlein nephritis in children and adults. Am J Kidney Dis. 2006;47(6):993-1003. PubMed | Google Scholar

  19. Uppal SS, Hussain MA, Al-Raqum HA, Nampoory MR, Al-Saeid K, Al-AssousiA et al. Henoch-Schönlein's purpura in adults versus children/adolescents: a comparative study. Clin Exp Rheumatol. 2006;24(2 suppl41):S26-30. PubMed | Google Scholar

  20. Pillebout E, Alberti C, Guillevin L, Ouslimani A, Thervet E, CESAR study group. Addition of cyclophosphamide to steroids provides no benefit compared with steroids alone in treating adult patients with severe Henoch Schönlein Purpura. Kidney Int. 2010;78(5):495-502. PubMed | Google Scholar

  21. Shrestha S, Sumingan N, Tan J, Alhous H, McWilliams L, Ballardie F. Henoch Schönlein purpura with nephritis in adults: adverse prognostic indicators in a UK population. QJM. 2006; 99(4):253-65. PubMed | Google Scholar

  22. Faull RJ, Aarons I, Woodroffe AJ, Clarkson AR. Adult Henoch-Schönlein nephritis. Aust N Z J Med. 1987;17(4):396-401. PubMed | Google Scholar

  23. Donnithorne KJ, Atkinson TP, Hinze CH, Nogueira JB, Saeed SA, Askenazi DJ. Rituximab therapy for severe refractory chronic Henoch-Schönlein purpura.J Pediatr. 2009;155(1):136-9. PubMed | Google Scholar

  24. Pillebout E, Rocha F, Fardet L, Rybojad M, Verine J, Glotz D. Successful out-come using rituximab as the only immunomodulation in Henoch-Schönlein purpura: case report. Nephrol Dial Transplant. 2011;26(6):2044-6. PubMed | Google Scholar